HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection: an IgA gene and functional analysis-Reference-Cited by-同舟云学术

HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection: an IgA gene and functional analysis

Published:2009-07-08 Issue:5 Volume:2 Page:412-426
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Tudor D,Derrien M,Diomede L,Drillet A-S,Houimel M,Moog C,Reynes J-M,Lopalco L,Bomsel M

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/mi200989.pdf

Reference75 articles.

1. Mazzoli, S. et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 3, 1250–1257 (1997).

2. Piacentini, L., Fenizia, C., Naddeo, V. & Clerici, M. Not just sheer luck! Immune correlates of protection against HIV-1 infection. Vaccine 26, 3002–3007 (2008).

3. Hirbod, T. & Broliden, K. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women. J. Intern. Med. 262, 44–58 (2007).

4. Miyazawa, M., et al. & group f. t. E. s. The “immunologic advantage” of HIV-exposed seronegative individuals. AIDS 23, 161–175 (2009).

5. Biasin, M. et al. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals. J. Infect. Dis. 195, 960–964 (2007).

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity;European Journal of Pharmaceutics and Biopharmaceutics;2023-10

2. Resistencia natural a la infección por el VIH-1. Revisión sistemática de la literatura;Iatreia;2023-03-13

3. Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA;Frontiers in Immunology;2023-02-02

4. Intracellular immunoglobulin A (icIgA) in protective immunity and vaccines;Scandinavian Journal of Immunology;2023-01-10

5. Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis;Frontiers in Immunology;2022-09-29